These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22038279)

  • 1. The biological characteristics of glioma stem cells in human glioma cell line SHG44.
    Liu L; Li WY; Chen Q; Zheng JK; Yang LY
    Mol Med Rep; 2012 Feb; 5(2):552-8. PubMed ID: 22038279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cancer stem cells (CD133(+)) in malignant gliomas.
    Cho DY; Lin SZ; Yang WK; Hsu DM; Lin HL; Lee HC; Lee WY; Chiu SC
    Cell Transplant; 2011; 20(1):121-5. PubMed ID: 20887676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell markers in gliomas.
    Dell'Albani P
    Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
    Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
    PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the proliferation and drug-resistance of human brain tumor stem-like cells.
    Qin K; Jiang X; Zou Y; Wang J; Qin L; Zeng Y
    Cell Mol Neurobiol; 2010 Aug; 30(6):955-60. PubMed ID: 20526804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.
    Bidlingmaier S; Zhu X; Liu B
    J Mol Med (Berl); 2008 Sep; 86(9):1025-32. PubMed ID: 18535813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of cancer stem cells from transformed human mesenchymal stem cell line F6.
    Xu X; Qian H; Zhu W; Zhang X; Yan Y; Wang M; Xu W
    J Mol Med (Berl); 2010 Nov; 88(11):1181-90. PubMed ID: 20697686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
    Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
    Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods.
    Shen G; Shen F; Shi Z; Liu W; Hu W; Zheng X; Wen L; Yang X
    In Vitro Cell Dev Biol Anim; 2008; 44(7):280-9. PubMed ID: 18594936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
    Cheng RB; Ma RJ; Wang ZK; Yang SJ; Lin XZ; Rong H; Ma Y
    Mol Cell Biochem; 2011 Mar; 349(1-2):149-57. PubMed ID: 21110069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cancer stem cells from the C6 glioma cell line.
    Zhou XD; Wang XY; Qu FJ; Zhong YH; Lu XD; Zhao P; Wang DH; Huang QB; Zhang L; Li XG
    J Int Med Res; 2009; 37(2):503-10. PubMed ID: 19383245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.
    Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R
    Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
    Wu A; Oh S; Wiesner SM; Ericson K; Chen L; Hall WA; Champoux PE; Low WC; Ohlfest JR
    Stem Cells Dev; 2008 Feb; 17(1):173-84. PubMed ID: 18271701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.